In order to investigate whether intermittent hypoxia (IH), one of the main features of OSA, contributes to liver steatosis and to the increase of CD36 expression observed in OSA patients, a mouse experimental model of OSA was used. The gene discussed is CD36; the disease is fatty liver disease.